Close Menu
  • Home
  • Vaccines
  • Politics
  • Health
  • Tech
  • Sports
  • Research
  • Fitness
  • Careers
What's Hot

Health Canada approves Novartis’ KISQALI® for HR+/HER2- early breast cancer patients at high risk of recurrence

Sheriff, county lawyer seeking mental health funds at Minnesota State Capitol

Chronic absences have not disappeared. Research shows that poor children are most hurt.

Facebook X (Twitter) Instagram
subjectional.com
Subscribe
  • Home
  • Vaccines
  • Politics
  • Health
  • Tech
  • Sports
  • Research
  • Fitness
  • Careers
subjectional.com
Home » Sabra Health Care REIT, Inc. Announces Third Quarter 2024 Earnings Release Date and Conference Call
Featured Health

Sabra Health Care REIT, Inc. Announces Third Quarter 2024 Earnings Release Date and Conference Call

Paul E.By Paul E.October 17, 2024No Comments1 Min Read
Share Facebook Twitter Pinterest Copy Link Telegram LinkedIn Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email


TUSTIN, Calif., Oct. 17, 2024–(BUSINESS WIRE)–Sabra Healthcare REIT, Inc. (NASDAQ: SBRA) today announces its 2024 third quarter financial results for trading on October 31, 2024. They announced that they would make an announcement after the event. of trading.

A concurrent conference call and webcast to discuss third quarter 2024 financial results will be held on Friday, November 1 at 10:00 a.m. Pacific Time. The dial-in number for US participants is 888-880-4448. For participants outside the United States, the dial-in number is 646-960-0572. The conference ID number is 1382596.

The webcast URL is https://events.q4inc.com/attendee/444925126. A digital replay of the call is available on our website at www.sabrahealth.com.

About Sabra

Sabra Health Care REIT, Inc., a Maryland corporation, operates as a self-managed real estate investment trust (“REIT”) that owns and invests in real estate serving the health care industry through its subsidiaries. USA and Canada.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241017615948/en/

contact address

Investor and Media Inquiries: 1-888-393-8248 or investorinquiries@sabrahealth.com



Source link

Follow on Google News Follow on Flipboard
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Copy Link
Previous ArticlePertussis cases reach highest level in 10 years in US
Next Article Insights and best practices to accelerate your healthcare career
Paul E.
  • Website

Related Posts

Health Canada approves Novartis’ KISQALI® for HR+/HER2- early breast cancer patients at high risk of recurrence

June 18, 2025

Sheriff, county lawyer seeking mental health funds at Minnesota State Capitol

June 5, 2025

Better Choice Company announces SRX Health closure

April 25, 2025
Leave A Reply Cancel Reply

Latest Posts

Health Canada approves Novartis’ KISQALI® for HR+/HER2- early breast cancer patients at high risk of recurrence

Sheriff, county lawyer seeking mental health funds at Minnesota State Capitol

Chronic absences have not disappeared. Research shows that poor children are most hurt.

Transport Secretary reveals overhaul of aging pneumatic transport systems

Latest Posts

Subscribe to News

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

Welcome to Subjectional!

At Subjectional, we believe that informed opinions are the foundation of a vibrant society. Our mission is to provide insightful, engaging, and balanced information across a diverse range of topics that matter to you. Whether you’re interested in the latest developments in health, navigating the complexities of politics, staying updated on sports, exploring technological advancements, or advancing your career, we’ve got you covered.

Facebook X (Twitter) Instagram Pinterest YouTube

Subscribe to Updates

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

Facebook X (Twitter) Instagram Pinterest
  • Home
  • About Us
  • Advertise with Us
  • Contact us
  • DMCA
  • Privacy Policy
  • Terms & Conditions
© 2025 subjectional. Designed by subjectional.

Type above and press Enter to search. Press Esc to cancel.